CROSSROADS STRATEGIES, LLC for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
General education about policies to improve outcomes for patients with APOL-1 kidney disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHERYL LYNN JAEGER | — |
Health Issues HCR
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about sickle cell disease therapy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Medical/Disease Research/Clinical Labs MED
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about sickle cell disease therapy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Medicare/Medicaid MMM
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALIM ALAMEDDIN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.